公司資料
Novavax 股價、新聞與催化劑
- 股票代碼:
- NVAX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
10.00 USD (+6.95%)
收盤價
最後更新: 2026年9月17日
1.68B USD
市值
股價為何變動
截至 2026年9月17日，NVAX 上漲 6.95%，收於 $10.00。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Novavax is a vaccine company centered on protein-based immunization and respiratory-disease programs. Its story has been shaped by the challenge of turning platform science into durable commercial execution.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Novavax sits in specialty vaccine biotechnology.
商業模式特徵
The business depends on vaccine demand, partnerships, regulatory progress, and the ability to sustain a post-pandemic franchise.
生技產業定位
Novavax is a vaccine catalyst name where commercial and regulatory updates can quickly shift sentiment.
未來催化劑
- Novavax's catalysts are the COVID/flu-combo program, seasonal-vaccine partnerships, and royalty momentum from its vaccine platform. The company still needs the platform to keep broadening.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。